Vor Biopharma (VOR) Non Operating Income (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non Operating Income data on file, last reported at -$184.4 million in Q1 2026.

• Non Operating Income for Q1 2026 came in at -$184.4 million, down 23009.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$509.6 million (down 14437.9% YoY), and the FY2025 annual result was -$324.3 million, down 7693.98% from the prior year.
• Non Operating Income fell to -$184.4 million in Q1 2026 per VOR's latest filing, from $1.8 billion in the prior quarter.
• Over five years, Non Operating Income peaked at $1.8 billion in Q4 2025 and troughed at -$1.3 billion in Q2 2025.
• A 5-year average of -$29.1 million and a median of $815000.0 in 2022 frame the typical range for Non Operating Income.
• On a YoY basis, Non Operating Income climbed as much as 293525.71% in 2025 and fell as far as 108744.23% in 2025.
• A 5-year view of Non Operating Income shows it stood at $815000.0 in 2022, then soared by 128.59% to $1.9 million in 2023, then sank by 67.85% to $599000.0 in 2024, then soared by 293525.71% to $1.8 billion in 2025, then plunged by 110.49% to -$184.4 million in 2026.
• Business Quant data shows VOR's Non Operating Income at -$184.4 million in Q1 2026, $1.8 billion in Q4 2025, and -$784.6 million in Q3 2025.